Document is current

Article History

Accepted: 15 July 2024

First Online: 30 July 2024

Declarations

:

: The current analysis was partly funded by an unrestricted research grant from Gilead Sciences, Denmark to Nordic Institute of Health Economics and Aarhus University, respectively. The funding source approved the overall design of the study prior to initiating analyses. The funding source had no influence on the final study design and methods, data collection, analysis, interpretation of results, or decision to publish. The funding source was provided with the opportunity to comment on the manuscript, while the final version was solely based on the discretion of the authors.

: M.S. received travel grants from AbbVie and is a current equity holder in Ambu. T.B.R. has no conflicts to declare. M.N. has no conflicts to declare. C.S.L. has received honoraria for lectures and participating in Advisory Boards from Gilead, GSK, and MSD. L.H.E. received consultancy fees or research funding from AbbVie, AstraZeneca, Boehringer Ingelheim, Gilead, GSK, Janssen, Merck, Pfizer, Radiometer, and Specsavers.

: According to Danish legislation, our approvals to use the Danish data sources for the current study do not allow us to distribute or make patient data directly available to other parties. The full health economic model is available in a TreeAge viewer version at . The health economic model can also be accessed at . This repository allows for the user to conduct different analyses such as cost-effectiveness analyses, Tornado analyses, and Markov cohort analyses.

: Studies based solely on data from the Danish national registers by Danish legislation do not require approval from the Danish Health Research Ethics committees, as study participants are never contacted, and consent is not required for the use of register information. The study was reported to the Danish Data Protection Agency through registration at Aarhus University (record number KEA-2017-36/605).

: Please see 6.3 Availability of data and material.

: Not applicable.

: Not applicable.

: All named authors meet the International Committee of Medical Journal Editors (ICMJE) guidelines for authorship for this article. All authors contributed to the design and conceptualization of the analyses. M.S. was responsible for the first draft of the Markov model. T.B.R. was responsible for the cohort study. M.S. and L.H.E. wrote the first draft of the manuscript. C.S.L. and M.N. critically revised model inputs and assumptions and contributed to the manuscript for important intellectual content. All authors were responsible for data acquisition, analysis, and interpretation and approved the final version of the manuscript.